期刊文献+

T-幼淋细胞白血病1例并文献复习

T-cell prolymphocytic leukemia in one case and the literature review
原文传递
导出
摘要 目的:分析总结T-幼淋细胞白血病的临床特点、诊断及治疗现状。方法:回顾性分析1例T-幼淋细胞白血病患者临床资料并复习相关文献。结果:骨髓穿刺可见幼淋细胞,流式细胞学分析示CD2+CD3+CD5+CD7+CD8+CD4-TdT-HLA-DR-CD1a-CD19-。染色体:46,XX,inv(14)(q11;q32)。给予化疗,化疗第10天突发低血容量性休克自动出院。结论:T-幼淋细胞白血病是一种少见的胸腺后淋巴细胞增殖性疾病,侵袭性高,中位生存期短。多种新药的临床应用及异基因干细胞移植为该病提供了治疗前景。 Objective To analyze and summarize the clinical characteristics,the diagnosis and the therapy of T-cell prolymphocytic leukemia.Methods The clinical data of one patient with T-cell prolymphocytic leukemia were investigated retrospectively and the relevant literature was reviewed.Results The bone marrow picture showed prolymphocytic T-cell.Flow cytometry showed that these abnormal cells expressed CD2+ CD3+CD5+CD7+CD8+CD4-TdT-HLA-DR-CD1a-CD19-.Chromosome analysis had the following karyotype: 46,XX,inv(14)(q11;q32).This patient received CHOP therapy and achieved therapeutic effect.The patient left the hospital due to hypovolemic shock on the tenth day.Conclusion T-cell prolymphocytic leukemia is a rare lymphoproliferative disease,with high invasive ability and short median survival time.Some new drugs and allogeneic hemotoic stem cell transplantation supply more therapeutic selection.
出处 《中华实用诊断与治疗杂志》 2011年第7期674-676,共3页 Journal of Chinese Practical Diagnosis and Therapy
关键词 白血病 T幼淋细胞 诊断 化疗 Leukemia prolymphocytic T-cell diagnosis chemotherapy
  • 相关文献

参考文献10

  • 1Catovsky D, Galetto J, Okos A, et aL. Prolymphocytic leukaemiaof Band T cell type[J]. Lancet,1973,2(7823):232-234.
  • 2Stern M H. Transgenic models of T-cell prolymphocytic leukaemia[J]. Haematologiea, 1999,84(4) : 64-66.
  • 3de Olivelra F M, Tone L G, Simoes B P, eta& Translocations t (X; 14) (q28; qll) and t (Y; 14) (q12; qll) in T-cellprolymphocytic leukemia[J]. Int J Lab Hematol, 2009,31 (4) : 453-456.
  • 4Catovsky D. Prolymphocytic leukaernia [J ]. Nouv Rev Fr Hematol, 1982,24 (6) : 343-347.
  • 5Pawson R, Dyer M J, Barge R, et al. Treatment of T-cell prolymphocytic leukemia with human CD52 antibody[J]. J Clin Onco1,1997,15(7):2667-2672.
  • 6Valiev T T, Vinogradova IuE, Chernova N G, et al. Remission in T cell prolymphocytic leukemia during the FMC treatment course[J]. Ter Arkh,2006,78(7):87-90.
  • 7Dearden C E. T cell prolymphocytic leukemia[J]. Med Oncot, 2006,23(1):17-22.
  • 8Ozpuyan F, Meyer P, Masri H A, et al. Bortezomib induces apoptosis in T-cell prolymphocytie leukemia (T PLL)[J]. l.euk Lymphoma,2007,48(11) :2247-2250.
  • 9Okamura K, Ikeda T, Shimakura Y, et al. Allogeneic bone transplantation for chemotherapy-resistant Tprolymphocytic leukemia [J ]. Rinsho Ketsueki, 2005, .16 (7): 527-531.
  • 10Khot A, Dearden C. T cell prolymphocytic leukemia [J]. Expert Rev Anticancer Ther,2009,9(3) :365-371.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部